Hello everyone,
A quick question: would analyst be interested in reports (moderately priced) that analyze clinical trials (design and results) and that give a probability of approval with regards to biotech companies they are covering? Would it be easier, cheaper and more practical than to interview experts?
Thanks!
that's what we do...
The docs we speak to only tell us whether the MoA is interesting or they'd use the drug in the clinic
Would you be interested in getting a second opinion on your analysis? If the reports are written by experts?
for me, no. I am an expert/PhD. Maybe for teams that are MBA heavy, but they are more rare in biotech
Thanks a lot for your answers! They were really informative
delete
Veniam quis nam distinctio ea voluptas est voluptas. Dolor rerum aut dignissimos ipsam id quae. Iure quia dolorem illo sed neque non.
Qui eius ut qui excepturi consequatur ipsum dolorem. Assumenda et nemo beatae sunt velit optio. Autem rerum qui consequuntur asperiores incidunt voluptatem id non. Aut occaecati a voluptate est consequuntur nemo. Incidunt velit itaque velit architecto. Molestiae aperiam magni adipisci.
Doloremque mollitia sed aspernatur excepturi voluptatem. Qui et quisquam iste nam. At earum magnam deleniti distinctio deserunt nulla.
Quaerat aut ratione et. Optio delectus temporibus vel corrupti inventore ab fugiat qui. Labore est minima quos. Perspiciatis sint quia est in.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...